Evaluation of the abuse potential of pitolisant, a selective H(3)-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy

OBJECTIVES: To evaluate the human abuse potential of pitolisant, a selective histamine 3 (H(3))-receptor antagonist/inverse agonist recently approved by the US Food and Drug Administration for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. METHODS: Nondependent, rec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sleep
Autori principali: Setnik, Beatrice, McDonnell, Michael, Mills, Catherine, Scart-Grès, Catherine, Robert, Philippe, Dayno, Jeffrey M, Schwartz, Jean-Charles
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Neurological Disorders
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157189/
https://ncbi.nlm.nih.gov/pubmed/31626696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/sleep/zsz252
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi